Free Trial

Verici Dx (VRCI) Competitors

Verici Dx logo
GBX 2.51 -0.11 (-4.27%)
(As of 12/20/2024 10:26 AM ET)

VRCI vs. YGEN, ABDX, GDR, PRM, GENI, LLAI, IDHC, DMTR, LLA, and DXRX

Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include Yourgene Health (YGEN), Abingdon Health (ABDX), genedrive (GDR), Proteome Sciences (PRM), GENinCode (GENI), LungLife AI (LLAI), Integrated Diagnostics (IDHC), Deepmatter Group (DMTR), LLA.L,0P0001T9GN,0 (LLA), and Diaceutics (DXRX). These companies are all part of the "diagnostics & research" industry.

Verici Dx vs.

Yourgene Health (LON:YGEN) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability, community ranking and analyst recommendations.

Yourgene Health has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500. Comparatively, Verici Dx has a beta of 1.59, suggesting that its stock price is 59% more volatile than the S&P 500.

23.3% of Yourgene Health shares are held by institutional investors. Comparatively, 51.9% of Verici Dx shares are held by institutional investors. 64.4% of Yourgene Health shares are held by company insiders. Comparatively, 17.1% of Verici Dx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Verici Dx has lower revenue, but higher earnings than Yourgene Health. Verici Dx is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yourgene Health£29.67M0.00-£8.17M-£0.01N/A
Verici Dx£4.33M1.41-£4.81M-£0.02-125.65

In the previous week, Yourgene Health's average media sentiment score of 0.00 equaled Verici Dx'saverage media sentiment score.

Company Overall Sentiment
Yourgene Health Neutral
Verici Dx Neutral

Yourgene Health received 17 more outperform votes than Verici Dx when rated by MarketBeat users.

CompanyUnderperformOutperform
Yourgene HealthOutperform Votes
17
53.13%
Underperform Votes
15
46.88%
Verici DxN/AN/A

Yourgene Health has a net margin of -27.55% compared to Verici Dx's net margin of -110.99%. Yourgene Health's return on equity of -27.06% beat Verici Dx's return on equity.

Company Net Margins Return on Equity Return on Assets
Yourgene Health-27.55% -27.06% -6.71%
Verici Dx -110.99%-58.12%-26.14%

Summary

Yourgene Health beats Verici Dx on 8 of the 11 factors compared between the two stocks.

Get Verici Dx News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRCI vs. The Competition

MetricVerici DxDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£6.10M£27.75M£5.14B£1.88B
Dividend YieldN/A5.44%5.09%5.54%
P/E Ratio-125.652.0090.051,810.29
Price / Sales1.412,398.621,117.14382,807.21
Price / Cash1.3111.4243.0428.42
Price / Book0.633.044.782.91
Net Income-£4.81M£53.40M£120.31M£156.83M
7 Day Performance-4.27%-3.11%-1.92%-1.92%
1 Month Performance-23.85%-0.11%11.51%17.93%
1 Year Performance-73.55%-14.32%30.61%29.50%

Verici Dx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRCI
Verici Dx
N/AGBX 2.51
-4.3%
N/A-73.5%£6.10M£4.33M-125.6519Gap Down
YGEN
Yourgene Health
N/AGBX 0.52
flat
N/A+0.0%£16.43M£29.67M-51.50253
ABDX
Abingdon Health
N/AGBX 7.23
-1.1%
N/A-10.6%£13.71M£6.13M-899.0084
GDR
genedrive
N/AGBX 2.25
flat
N/A-74.1%£12.22M£49,000.00-57.4843Insider Trade
News Coverage
Positive News
Gap Up
PRM
Proteome Sciences
N/AGBX 2.68
+1.1%
N/A-38.3%£7.91M£4.04M-291.00240Gap Up
GENI
GENinCode
N/AGBX 3.80
flat
N/A-30.2%£6.72M£2.60M-78.522,300Gap Up
LLAI
LungLife AI
N/AGBX 9.50
flat
N/A-81.1%£2.91M£98,566.00-69.2315High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.44
-2.2%
N/A+23.3%£2.57M£4.75B14.756,692Gap Down
DMTR
Deepmatter Group
N/AGBX 0.03
+22.2%
N/AN/A£1.33M£1.04M-0.11N/AGap Down
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-125.0015High Trading Volume
DXRX
Diaceutics
2.4147 of 5 stars
GBX 119.50
-1.2%
GBX 160
+33.9%
+39.8%£100.94M£26.09M-3,983.33151Analyst Forecast
News Coverage
High Trading Volume

Related Companies and Tools


This page (LON:VRCI) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners